首页|骨碎补活性成分促进骨缺损后骨重建的机制及其组织工程学应用

骨碎补活性成分促进骨缺损后骨重建的机制及其组织工程学应用

扫码查看
原文链接
  • 国家科技期刊平台
  • NETL
  • NSTL
  • 万方数据
骨缺损的治疗难度大、周期长，一直都是骨科临床面临的重大挑战。骨碎补是我国中医骨伤科的常用药材，其活性成分(主要为黄酮类)可促进骨髓间充质干细胞成骨分化、成骨细胞增殖、成血管-成骨耦联，抑制破骨细胞活力，从而促进骨缺损区的骨质矿化和修复重建。骨碎补活性成分是骨再生治疗药物的良好替代品，将其负载于组织工程支架材料上，可极大地提高药物的生物利用度。同时，缓释微球进一步解决了支架药物的突发性释放等问题，应用其所制备的含骨碎补活性成分的复合支架具有较好的成骨活性和骨诱导性，骨修复效果确切，可满足骨移植物的多样化性能要求，临床应用前景广阔。
Mechanism and application in tissue engineering of the active ingredient of Drynariae Rhizoma promoting bone defect repair
Bone defect has always been a major clinical challenge because of its great difficulty and long period of treatment.Drynariae Rhizoma is a commonly used medicine in osteology and traumatology of traditional Chinese medicine,and its active ingredients(mainly flavonoids)facilitate osteoblast differentiation of bone marrow mesenchymal stem cells,osteoclast proliferation,vascular-osteogenic coupling,and inhibit osteoclast activity to promote bone mineralization,and repair and reconstruction of bone defect.As a good substitute for bone regeneration drugs,the active constituents of Drynariae Rhizoma can be loaded on scaffold materials of tissue engineering,which greatly improves the bioavailability of the drug.Meanwhile,the sustained-release microspheres also solve some problems such as sudden drug release from the scaffolds,and the composite scaffolds with active ingredient of Drynariae Rhizoma prepared by them have good ossification activity and osteoinduction,with precise bone repair effects,which meet the diverse performance requirements of bone grafts and have a promising clinical application prospect.

Drynariae Rhizomaactive ingredienttotal flavonoidsbone defectbone tissue engineering

邓志军、杨文龙、杨智军、赵斌、李典、杨凤云

展开 >

江西中医药大学研究生院,南昌 330004

江西中医药大学附属医院骨科,南昌 330006

骨碎补 活性成分 总黄酮 骨缺损 骨组织工程

全国名老中医药专家传承工作室建设项目江西省省级科技计划江西省中医药局重点研究室、临床研究基地建设项目江西省研究生创新专项江西中医药大学大学生创新创业训练计划

国中医药人教函[2022]75号20212-BCG74004赣中医药科教字[2020]6号YC2022-s876X202310412165

2024

10.6039/j.issn.1001-0408.2024.08.22

中国药房
中国医院协会,中国药房杂志社

中国药房

CSTPCD北大核心
影响因子：0.956
ISSN：1001-0408
年,卷(期)：2024.35(8)
  • 51